Based on recent data, Psyence Biomedical Ltd. (PBM) shows an Average True Range (ATR) of 0.74 and an Enterprise Value of N/A. Its average trading volume over the past 3 months is 379.54K, indicating liquidity. These fundamental metrics provide insight into PBM's underlying financial health and market activity.
| ATR | 0.74 |
| Enterprise Value | - |
| Avg Vol (3 Months) | 379.54K |
| Avg Vol (10 Days) | 31.95K |
Psyence Biomedical Ltd. (PBM) technical indicators as of February 22, 2026: the SMA 20 is -26.36%, SMA 50 at -52.14%, and SMA 200 at -87.52%. The RSI 14 value is 31.04, suggesting its current momentum. These technical analysis signals help assess PBM's price trends and potential future movements.
| SMA 20 | -26.36% |
| SMA 50 | -52.14% |
| SMA 200 | -87.52% |
| RSI 14 | 31.04 |
Psyence Biomedical Ltd. (PBM) stock performance overview as of February 22, 2026: The 52-week high is $74.938 (currently -96.66% below), and the 52-week low is $0.615 (currently 3.31% above). Over the past year, PBM's performance is -94.87%, compared to the S&P 500's 7.96% change.
| 52-Week High | 74.938 |
| 52-Week High Chg | -96.66% |
| 52-Week Low | 0.6147 |
| 52-Week Low Chg | +3.31% |
| S&P 500 52-Week Chg | 7.96% |
According to market data, Psyence Biomedical Ltd. (PBM) stock's recent performance metrics show that over the last month, PBM is -56.21%, with a Year-to-Date (YTD) performance of -11.07%. Over the past year, the stock has seen a -94.87% change. These figures summarize PBM's price movements across various periods, reflecting its historical returns.
| Period | 1 Week | 1 Month | Quarter | Half Year | 1 Year | YTD |
|---|---|---|---|---|---|---|
| High | 3.1 | 12.64 | 17.625 | 34.625 | 74.938 | 12.64 |
| Low | 2.42 | 0.6254 | 0.6147 | 0.6147 | 0.6147 | 0.6147 |
| Performance | -16.25% | -56.21% | -80.58% | -86.76% | -94.87% | -11.07% |
According to current financial data, PBM stock's P/E (TTM) ratio is -6.05, which compares to the S&P 500's P/E of 32.59. The sector median P/E is -1.23. Key valuation ratios for PBM, including P/S (N/A), P/B (0.31), and P/FCF (N/A), offer insights into how the company is valued relative to its earnings, sales, book value, and free cash flow.
| Valuation | PBM | Sector Median | Industry Avg | S&P 500 |
|---|---|---|---|---|
| P/E (TTM) | -6.05 | -1.23 | -5.16 | 32.59 |
| P/S (TTM) | N/A | 3.71 | 464.92 | 5.98 |
| P/B (TTM) | 0.31 | 0.64 | 8.48 | 5.16 |
| P/FCF (TTM) | N/A | -7.99 | -218.57 | 30.24 |
© 2026 Stocks Telegraph All rights reserved.
Most stock quote data provided by Financial Modeling Prep